Botox side effects: warning from FDA
If you're new here, you may want to subscribe to our RSS feed. Thanks for visiting!
Attention, Botox users. The US FDA has issued a public notification regarding the side effects of Botox use. The warning concerned the ongoing safety review of Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B).
The side effects observed ranged from mild to serious and life-threatening conditions, a few are listed below:
• allergic reactions
• weakness
• breathing problems
• difficulty in swallowing
• respiratory failure
Botox is short for botulism toxin, a neurotoxin produced by the bacterial species Clostridium botulinum. As its name suggest, it is a very toxic substance that causes muscle paralysis and death. However, it was discovered that in very small doses, the toxin can smoothen wrinkles, making it one of the most popular cosmetic treatments in developed countries.
The side effects described were related to both FDA-approved and non-FDA approved applications. Cosmetic operation with Botox is FDA-approved. Treatment of limb spasticity in patients with cerebral palsy is not. The latter treatment is linked to very serious adverse effects in children.
The FDA warning does not advice against the prescription of Botox. The safety review is still ongoing.
This post is for educational purposes only and is not intended as medical advice.
Reference:
Tags: Botox, FDA, side effects











